quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:06:59·52d
SECFiling
uniQure N.V. logo

uniQure N.V. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

QURE· uniQure N.V.
Health Care
Original source

Companies

  • QURE
    uniQure N.V.
    Health Care

Recent analyst ratings

  • Mar 11UpdateMizuho$35.00
  • Mar 9UpdateRBC Capital Mkts$35.00
  • Mar 9UpdateWells Fargo$60.00
  • Mar 3UpdateWells Fargo$15.00
  • Mar 3UpdateMizuho$12.00
  • Mar 2UpdateRBC Capital Mkts$11.00

Related

  • SEC7d
    SEC Form PRE 14A filed by uniQure N.V.
  • ANALYST43d
    uniQure upgraded by Mizuho with a new price target
  • INSIDER45d
    Chief Customer & Strat Officer O'Keefe Kylie was granted 19,800 units of Ordinary Shares, increasing direct ownership by 19% to 124,800 units (SEC Form 4)
  • INSIDER45d
    New insider O'Keefe Kylie claimed ownership of 105,000 units of Ordinary Shares (SEC Form 3)
  • ANALYST45d
    uniQure upgraded by RBC Capital Mkts with a new price target
  • ANALYST45d
    uniQure upgraded by Wells Fargo with a new price target
  • INSIDER48d
    CEO, Managing Director Kapusta Matthew C was granted 70,600 units of Ordinary Shares and sold $132,104 worth of Ordinary Shares (14,581 units at $9.06), increasing direct ownership by 9% to 660,658 units (SEC Form 4)
  • INSIDER48d
    Chief Medical Officer Abi-Saab Walid sold $7,320 worth of Ordinary Shares (808 units at $9.06) and was granted 41,700 units of Ordinary Shares, increasing direct ownership by 27% to 189,669 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022